======= AKAP10 =======
== Gene Information ==
* **Official Symbol**: AKAP10
* **Official Name**: A-kinase anchoring protein 10
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11216|11216]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O43572|O43572]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=AKAP10&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AKAP10|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604694|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the A-kinase anchor protein family. A-kinase anchor proteins bind to the regulatory subunits of protein kinase A (PKA) and confine the holoenzyme to discrete locations within the cell. The encoded protein is localized to mitochondria and interacts with both the type I and type II regulatory subunits of PKA. Polymorphisms in this gene may be associated with increased risk of arrhythmias and sudden cardiac death. [provided by RefSeq, May 2012].
* **UniProt Summary**: Differentially targeted protein that binds to type I and II regulatory subunits of protein kinase A and anchors them to the mitochondria or the plasma membrane. Although the physiological relevance between PKA and AKAPS with mitochondria is not fully understood, one idea is that BAD, a proapoptotic member, is phosphorylated and inactivated by mitochondria-anchored PKA. It cannot be excluded too that it may facilitate PKA as well as G protein signal transduction, by acting as an adapter for assembling multiprotein complexes. With its RGS domain, it could lead to the interaction to G-alpha proteins, providing a link between the signaling machinery and the downstream kinase (By similarity). {ECO:0000250}.
|RGS|
|protein kinase A binding|
|blood coagulation|
|coagulation|
|hemostasis|
|wound healing|
|regulation of body fluid levels|
|response to wounding|
|protein-containing complex|
|mitochondrion|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.67|
|[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-2.48|
|[[:results:exp79|Q15 2.7μM R02 exp79]]|-2.19|
|[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-2.15|
|[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-1.75|
|[[:results:exp486|Heregulin-B 44ng/ml R08 exp486]]|-1.72|
|[[:results:exp346|CoCl2 18μM R07 exp346]]|1.78|
|[[:results:exp38|Wortmannin 5μM R00 exp38]]|2.13|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5530
* **Expression level (log2 read counts)**: 5.36
{{:chemogenomics:nalm6 dist.png?nolink |}}